Ven Bio Global Strategic Fund Iii, L.P. Elevation Oncology, Inc. (ELEV) insider trading activity

Ven Bio Global Strategic Fund Iii, L.P. is of Elevation Oncology, Inc.. Currently has a direct ownership of 1.91 Million shares of ELEV, which is worth approximately $1.11 Million. The most recent transaction as insider was on May 25, 2022, when has been sold 702,737 shares (Common Stock) at a price of $4.12 per share, resulting in proceeds of $2,895,276. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.91M

0% 3M change

0% 12M change

Total Value Held $1.11 Million

venBio Global Strategic Fund III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 25 2022	SELL Open market or private sale	$2,895,276 $4.12 p/Share	702,737 Reduced 26.94%	1,905,430 Common Stock
Jun 29 2021	BUY Open market or private purchase	$10,000,000 $16.0 p/Share	625,000 Added 19.33%	2,608,167 Common Stock
Jun 29 2021	BUY Conversion of derivative security	-	1,983,167 Added 50.0%	1,983,167 Common Stock

Also insider at

VTYX

Ventyx Biosciences, Inc. Healthcare

> 10% Shareholder

RYZB

RayzeBio, Inc.

RTVA

Artiva Biotherapeutics, Inc.

vGS